476 related articles for article (PubMed ID: 14568946)
1. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
[TBL] [Abstract][Full Text] [Related]
2. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells.
Chen HC; Chou CK; Sun CM; Yeh SF
Antiviral Res; 1997 May; 34(3):137-44. PubMed ID: 9191021
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
6. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.
Shih CM; Lo SJ; Miyamura T; Chen SY; Lee YH
J Virol; 1993 Oct; 67(10):5823-32. PubMed ID: 8396658
[TBL] [Abstract][Full Text] [Related]
7. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
Fan HX; Feng YJ; Zhao XP; He YZ; Tang H
Life Sci; 2018 Nov; 213():9-17. PubMed ID: 30308183
[TBL] [Abstract][Full Text] [Related]
8. Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication.
Pei R; Qin B; Zhang X; Zhu W; Kemper T; Ma Z; Trippler M; Schlaak J; Chen X; Lu M
J Innate Immun; 2014; 6(2):182-91. PubMed ID: 23867918
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
Huang KL; Lai YK; Lin CC; Chang JM
World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
[TBL] [Abstract][Full Text] [Related]
11. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.
Buckwold VE; Xu Z; Chen M; Yen TS; Ou JH
J Virol; 1996 Sep; 70(9):5845-51. PubMed ID: 8709203
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 15 activates hepatitis B virus gene expression and replication.
Zhou J; Tan T; Tian Y; Zheng B; Ou JH; Huang EJ; Yen TS
Hepatology; 2011 Jul; 54(1):109-21. PubMed ID: 21503941
[TBL] [Abstract][Full Text] [Related]
13. SOX2 Represses Hepatitis B Virus Replication by Binding to the Viral EnhII/Cp and Inhibiting the Promoter Activation.
Yang H; Mo J; Xiang Q; Zhao P; Song Y; Yang G; Wu K; Liu Y; Liu W; Wu J
Viruses; 2020 Feb; 12(3):. PubMed ID: 32121397
[TBL] [Abstract][Full Text] [Related]
14. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression.
Chu X; Wu B; Fan H; Hou J; Hao J; Hu J; Wang B; Liu G; Li C; Meng S
Antiviral Res; 2016 Mar; 127():41-9. PubMed ID: 26784393
[TBL] [Abstract][Full Text] [Related]
15. Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.
Xu WZ; Fang Y; Li D; Wang Y; Shang QL; Li GQ; Teng X; Gu HX
World J Gastroenterol; 2008 Jun; 14(23):3733-8. PubMed ID: 18595141
[TBL] [Abstract][Full Text] [Related]
16. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
17. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
18. p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.
Xu ZH; Zhao MJ; Li TP
World J Gastroenterol; 2002 Dec; 8(6):1094-7. PubMed ID: 12439932
[TBL] [Abstract][Full Text] [Related]
19. Cytokine inhibition of the hepatitis B virus core promoter.
Romero R; Lavine JE
Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
